Jack Meehan
Stock Analyst at Barclays
(3.10)
# 1,238
Out of 4,711 analysts
131
Total ratings
69.51%
Success rate
21.42%
Average return
Main Sectors:
Stocks Rated by Jack Meehan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LH Labcorp Holdings | Maintains: Equal-Weight | $234 → $249 | $228.61 | +8.92% | 11 | Oct 25, 2024 | |
| A Agilent Technologies | Maintains: Underweight | $120 → $125 | $134.51 | -7.07% | 20 | Feb 28, 2024 | |
| WAT Waters | Maintains: Equal-Weight | $275 → $288 | $368.16 | -21.77% | 10 | Aug 3, 2023 | |
| AVTR Avantor | Initiates: Overweight | $33 | $21.21 | +55.59% | 3 | Mar 3, 2021 | |
| ILMN Illumina | Initiates: Underweight | $325 | $136.02 | +138.94% | 8 | Mar 3, 2021 | |
| INMD InMode | Maintains: Overweight | $18 → $19 | $17.08 | +11.24% | 3 | Aug 17, 2020 | |
| DGX Quest Diagnostics | Maintains: Equal-Weight | $93 → $99 | $153.10 | -35.34% | 7 | Apr 23, 2020 | |
| ICLR ICON Public Limited Company | Maintains: Overweight | $170 → $180 | $207.51 | -13.26% | 2 | Apr 23, 2020 | |
| MYGN Myriad Genetics | Maintains: Underweight | $14 → $10 | $13.36 | -25.15% | 8 | Mar 26, 2020 | |
| IQV IQVIA Holdings | Maintains: Overweight | $192 → $166 | $197.27 | -15.85% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $51 → $43 | $71.65 | -39.99% | 9 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $170 → $154 | $185.77 | -17.10% | 7 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $430 | $327.47 | +31.31% | 6 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $430 | $325.85 | +31.96% | 6 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | n/a | $44.84 | - | 10 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $52 → $48 | $57.00 | -15.79% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $720 → $680 | $1,230.74 | -44.75% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $28 → $30 | $102.93 | -70.85% | 3 | Oct 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $295 → $300 | $524.05 | -42.75% | 5 | Mar 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $40 | $1.49 | +2,584.56% | 1 | Dec 11, 2017 |
Labcorp Holdings
Oct 25, 2024
Maintains: Equal-Weight
Price Target: $234 → $249
Current: $228.61
Upside: +8.92%
Agilent Technologies
Feb 28, 2024
Maintains: Underweight
Price Target: $120 → $125
Current: $134.51
Upside: -7.07%
Waters
Aug 3, 2023
Maintains: Equal-Weight
Price Target: $275 → $288
Current: $368.16
Upside: -21.77%
Avantor
Mar 3, 2021
Initiates: Overweight
Price Target: $33
Current: $21.21
Upside: +55.59%
Illumina
Mar 3, 2021
Initiates: Underweight
Price Target: $325
Current: $136.02
Upside: +138.94%
InMode
Aug 17, 2020
Maintains: Overweight
Price Target: $18 → $19
Current: $17.08
Upside: +11.24%
Quest Diagnostics
Apr 23, 2020
Maintains: Equal-Weight
Price Target: $93 → $99
Current: $153.10
Upside: -35.34%
ICON Public Limited Company
Apr 23, 2020
Maintains: Overweight
Price Target: $170 → $180
Current: $207.51
Upside: -13.26%
Myriad Genetics
Mar 26, 2020
Maintains: Underweight
Price Target: $14 → $10
Current: $13.36
Upside: -25.15%
IQVIA Holdings
Mar 26, 2020
Maintains: Overweight
Price Target: $192 → $166
Current: $197.27
Upside: -15.85%
Mar 26, 2020
Maintains: Equal-Weight
Price Target: $51 → $43
Current: $71.65
Upside: -39.99%
Mar 26, 2020
Maintains: Equal-Weight
Price Target: $170 → $154
Current: $185.77
Upside: -17.10%
Mar 26, 2020
Maintains: Overweight
Price Target: $435 → $430
Current: $327.47
Upside: +31.31%
Mar 26, 2020
Maintains: Overweight
Price Target: $435 → $430
Current: $325.85
Upside: +31.96%
Mar 26, 2020
Downgrades: Equal-Weight
Price Target: n/a
Current: $44.84
Upside: -
Mar 26, 2020
Upgrades: Overweight
Price Target: $52 → $48
Current: $57.00
Upside: -15.79%
Mar 26, 2020
Upgrades: Equal-Weight
Price Target: $720 → $680
Current: $1,230.74
Upside: -44.75%
Oct 2, 2019
Maintains: Underweight
Price Target: $28 → $30
Current: $102.93
Upside: -70.85%
Mar 18, 2019
Maintains: Overweight
Price Target: $295 → $300
Current: $524.05
Upside: -42.75%
Dec 11, 2017
Initiates: Equal-Weight
Price Target: $40
Current: $1.49
Upside: +2,584.56%